REVIEW PAPER
Smoking as a Crucial Independent Determinant of Stroke
 
More details
Hide details
1
National Stroke Research Institute, Austin Health, Victoria, Australia
CORRESPONDING AUTHOR
Geoffrey A. Donnan   

National Stroke Research Institute, Neurosciences Building, Austin Health – Repatriation Campus, 300 Waterdale Road, West Heidelberg, Victoria 3081, Australia
Publication date: 2004-06-15
 
Tobacco Induced Diseases 2004;2(June):67
 
KEYWORDS
ABSTRACT
Background: Although smoking is known to be powerful risk factor for other vascular diseases, such as cardiac and peripheral vascular disease, only relatively recently has evidence for the role of smoking in the development of stroke been established. The reasons for this advance lie in the acknowledgement that stroke is a heterogeneous disease, in which its subtypes are associated with different risk factors. Furthermore, improvements in the stringency of epidemiological studies and the greater use of CT scanning have enabled the role of smoking in the development of stroke to be elucidated.

Summary of review: This is a qualitative examination of high quality epidemiological studies in which the role of smoking and passive smoking, as a risk factor for cerebral infarction, intracerebral haemorrhage and subarachnoid haemorrhage, is examined. In addition, the pathological mechanisms by which smoking or passive smoking may contribute to the development of stroke are reviewed.

Conclusion: Smoking is a crucial independent determinant of cerebral infarction and subarachnoid haemorrhage, however its role in intracerebral haemorrhage is unclear. Although studies are limited, there is evidence that exposure to passive smoking may also increase the risk of stroke. Smoking appears to be involved in the pathogenesis of stroke via direct injury to the vasculature and also by altering haemodynamic factors within the circulation. Importantly, smoking is modifiable risk factor for stroke. Therefore, the encouragement of smoking cessation may result in a substantial reduction in the incidence of this devastating disease.
 
REFERENCES (74)
1.
Hughson W, Mann J, Garrod A: Intermittent claudication prevalence and risk factors. British Medical Journal. 1978, 1: 1379-1381. 10.1136/bmj.1.6124.1379.
 
2.
Gordon T, Kannel WB: Predisposition to atherosclerosis in the head, heart and legs: the Framingham Study. Journal of the American Medical Association. 1972, 221: 661-666. 10.1001/jama.221.7.661.
 
3.
Aldoori MI, Rahman SH: Smoking and stroke: a causative role. Heavy smokers with hypertension benefit most from stopping. British Medical Journal. 1998, 317: 762-3.
 
4.
Bell BA, Ambrose J: Smoking and the risk of stroke. Acta Neurochirurgica. 1982, 64: 1-7. 10.1007/BF01405614.
 
5.
Berger K, Schulte H, Stogbauer F, Assmann G: Incidence and risk factors for stroke in an occupational cohort: the PROCAM study. Stroke. 1998, 29: 1562-1566.
 
6.
Bonita R: Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: a population-based case-control study. Stroke. 1986, 17: 831-835.
 
7.
Bonita R, Scragg R, Stewart A, Jackson RT, Beaglehole R: Cigarette smoking and the risk of premature stroke in men and women. British Medical Journal. 1986, 293: 6-8. 10.1136/bmj.293.6538.6.
 
8.
Bonita R, Duncan J, Truelsen T, Jackson RT, Beaglehole R: Passive smoking as well as active smoking increases the risk of acute stroke. Tobacco Control. 1999, 8: 156-160. 10.1136/tc.8.2.156.
 
9.
Colditz GA, Bonita R, Stampfer MJ, Willett WC, Rosner B, Speizer FE, Hennekens CH: Cigarette smoking and risk of stroke in middle-aged women. New England Journal of Medicine. 1988, 318: 937-41.
 
10.
Donnan GA, McNeil JJ, Adena MA, Doyle AE, O'Malley HM, Neill GC: Smoking as a risk factor for cerebral ischaemia. Lancet. 1989, 2: 643-647. 10.1016/S0140-6736(89)90894-5.
 
11.
Feigin VL, Wiebers DO, Nikitin YP, O'Fallon WM, Whisnant JP: Risk factors for ischemic stroke in a Russian community: a population-based case-control study. Stroke. 1998, 29: 34-39.
 
12.
Gill JS, Shipley MJ, Tsementzis SA, Hornby R, Gill SK, Hitchcock ER, Beevers DG: Cigarette smoking: a risk factor for hemorrhagic and non-hemorrhagic stroke. Archives of Internal Medicine. 1989, 149: 2053-2057. 10.1001/archinte.149.9.2053.
 
13.
Gorelick PB, Rodin MB, Langenberg P, Hier DB, Costigan J: Weekly alcohol consumption, cigarette smoking, and the risk of ischemic stroke: results of a case-control study at three urban medical centers in Chicago, Illinois. Neurology. 1989, 39: 339-343.
 
14.
Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, Glahn J, Brandt T, Hacke W, Diener H-C: Risk factors, outcome and treatment in subtypes of ischemic stroke: the German Stroke Data Bank. Stroke. 2001, 32: 2559-2566. 10.1161/hs1101.098524.
 
15.
Haheim LL, Holme I, Hjermann I, Leren P: Smoking habits and risk of fatal stroke: 18 years follow-up of the Oslo study. Journal of Epidemiology and Community Health. 1996, 50: 621-624. 10.1136/jech.50.6.621.
 
16.
Isaksen J, Egge A, Waterloo K, Romner B, Ingebrigtsen T: Risk factors for aneurysmal subarachnoid haemorrhage: the Tromsø study. Journal of Neurology Neurosurgery and Psychiatry. 2002, 73: 185-187. 10.1136/jnnp.73.2.185.
 
17.
Jamrozik K, Broadhurst RJ, Anderson CS, Stewart-Wynne EG: The role of lifestyle factors in the etiology of stroke: a population-based case-control study in Perth, Western Australia. Stroke. 1994, 25: 51-59.
 
18.
Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH: Smoking cessation and decreased risk of stroke in women. Journal of the American Medical Association. 1993, 269: 232-236. 10.1001/jama.269.2.232.
 
19.
Kurth T, Kase CS, Berger K, Schaeffner ES, Buring JE, Gaziano M: Smoking and the risk of hemorrhagic stroke in men. Stroke. 2003, 34: 1151-1155. 10.1161/01.STR.0000065200.93070.32.
 
20.
Lidegaard Ø: Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. British Medical Journal. 1993, 306: 956-963. 10.1136/bmj.306.6883.956.
 
21.
Lee T-K, Huang Z-S, Ng S-K, Chan K-WA, Wang Y-S, Liu H-W, Lee J-J: Impact of alcohol consumption and cigarette smoking on stroke among the elderly in Taiwan. Stroke. 1995, 26: 790-794.
 
22.
Longstreth W, Nelson L, Koepsell T, van Belle G: Cigarette smoking, alcohol use and subarachnoid haemorrhage. Stroke. 1992, 23: 1242-1249.
 
23.
Love BB, Biller J, Jones MP, Adams HP, Bruno A: Cigarette smoking: a risk factor for cerebral infarction in young adults. Archives of Neurology. 1990, 47: 693-698.
 
24.
Monforte R, Estruch R, Graus F, Nicolas JM, Urbano-Marquez A: High ethanol consumption as risk factor for intracerebral hemorrhage in young and middle-aged people. Stroke. 1990, 21: 1529-1532.
 
25.
Petitti DB, Sidney S, Burnstein A, Wolf S, Quesenberry C, Ziel HK: Stroke in users of low-dose oral contraceptives. New England Journal of Medicine. 1996, 335: 8-15. 10.1056/NEJM199607043350102.
 
26.
Qureshi AI, Suri MFK, Yahia AM, Suarez JI, Guterman LR, Hopkins LN, Tamargo REJ: Risk factors for subarachnoid hemorrhage. Neurosurgery. 2001, 49: 607-612. 10.1097/00006123-200109000-00014.
 
27.
Rodriguez BL, D'Agostino TB, Abbot RD, Kagan A, Burchfiel AM, Yano K, Ross GW, Silbershatz H, Higgins MW, Popper J, Wolf PA, Curb JD: Risk of hospitalized stroke in men enrolled in the Honolulu heart program and the Framingham study: a comparison of incidence and risk factor effects. Stroke. 2002, 33: 230-237. 10.1161/hs0102.101081.
 
28.
Shinton R, Beevers G: Meta-analysis of relation between cigarette smoking and stroke. British Medical Journal. 1989, 298: 789-794. 10.1136/bmj.298.6676.789.
 
29.
Wannamethee SG, Shaper AG, Whincup PH, Walker M: Smoking cessation and the risk of stroke in middle-aged men. Journal of the American Medical Association. 1995, 274: 155-160. 10.1001/jama.274.2.155.
 
30.
Weir BKA, Kongable GL, Kassell NF, Schultz JR, Truskowski LL, Sigrest S: Cigarette smoking as a cause of aneurysmal subarachnoid haemorrhage and risk of vasospasm: a report of the Cooperative Aneurysm Study. Journal of Neurosurgery. 1998, 89: 405-411.
 
31.
Wolf PA, D'Agostino TB, Kannel WB, Bonita R, Belanger AJ: Cigarette smoking as a risk factor for stroke. Journal of the American Medical Association. 1988, 259: 1025-1029. 10.1001/jama.259.7.1025.
 
32.
You R, McNeil JJ, Hurley SF, Farish SJ, O'Malley HM, Quang L, Donnan GA: Smoking as a risk factor for cortical ischaemia presumably due to carotid occlusive disease. Neuroepidemiology. 1993, 12: 141-147. 10.1159/000110313.
 
33.
You R, Thrift AG, McNeil JJ, Davis SM, Donnan GA: Ischemic stroke risk and passive exposure to spouses' cigarette smoking. American Journal of Public Health. 1999, 89: 572-575. 10.2105/AJPH.89.4.572.
 
34.
Thrift AG, Dewey HM, Macdonell RAL, McNeil JJ, Donnan GA: Incidence of the major stroke subtypes. Initial findings from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke. 2001, 32: 1732-1738.
 
35.
Ellekjær EF, Wyller TB, Sverre JM, Holmen J: Lifestyle factors and risk of cerebral infarction. Stroke. 1992, 23: 829-834.
 
36.
Benfante R, Yano K, Hwang L-J, Curb JD, Kagan A, Ross W: Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men: implications of shared risk. Stroke. 1994, 25: 814-820.
 
37.
Sudlow CLM, Warlow CP: Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke. 1997, 28: 491-499.
 
38.
Hackett ML, Duncan JR, Anderson CS, Broad JB, Bonita R: Health-related quality of life among long-term survivors of stroke: results from the Auckland stroke study, 1991–1992. Stroke. 2000, 31: 440-7.
 
39.
Thrift AG, McNeil JJ, Donnan GA: The risk of intracerebral haemorrhage with smoking. Cerebrovascular Diseases. 1999, 9: 34-39. 10.1159/000015893.
 
40.
Woo D, Sauerbeck LR, Kissela BM, Khoury JC, Szaflarski JP, Gebel J, Shukla R, Pancioli AM, Jauch EC, Menon AG, Deka R, Carrozzella JA, Moomaw CJ, Fontaine RN, Broderick JP: Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke. 2002, 33: 1190-1196. 10.1161/01.STR.0000014774.88027.22.
 
41.
Ariesen MJ, Claus SP, Rinkel GJE, Algra A: Risk factors for intracerebral hemorrhage in the general population, a systematic review. Stroke. 2003, 34: 2065-2066. 10.1161/01.STR.0000080678.09344.8D.
 
42.
U.S. Environmental Protection Agency: Respiratory Health Effects of Passive Smoking: Lung Cancer and Other Disorders. 1992, Washington DC: Office of Research and Development.
 
43.
Lee PN, Chamberlain J, Alderson MR: Relationship of passive smoking to risk of lung cancer and other smoking-associated diseases. British Journal of Cancer. 1986, 54: 97-105.
 
44.
Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, Nieto J, Tell GS: Cigarette smoking and progression of atherosclerosis – The atherosclerosis risk in communities (ARIC) study. Journal of the American Medical Association. 1998, 279: 119-124. 10.1001/jama.279.2.119.
 
45.
Kiechl S, Werner P, Egger G, Oberhollenzer F, Mayr M, Xu Q, Poewe W, Willeit J: Active and passive smoking, chronic infections, and the risk of carotid athersclerosis: prospective results from the Bruneck Study. Stroke. 2002, 33: 2170-2176. 10.1161/01.STR.0000027209.59821.98.
 
46.
Conklin BS, Zhao W, Zhong D-S, Chen C: Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. American Journal of Pathology. 2002, 160: 413-418.
 
47.
Diezroux AV, Nieto FJ, Comstock GW, Howard G, Szklo M: The relationship of active and passive smoking to carotid atherosclerosis 12–14 years later. Preventive Medicine. 1995, 24: 48-55. 10.1006/pmed.1995.1007.
 
48.
Djousse L, Myers RH, Province MA, Hunt SC, Eckfeldt JH, Evans G, Peacock JM, Ellison RC: Influence of apolipoprotein E, smoking, and alcohol intake on carotid athersclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke. 2002, 33: 1357-1361. 10.1161/01.STR.0000014325.54063.1A.
 
49.
Fang Q, Sun H, Mayhan WG: Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotine. American Journal of Physiology – Heart and Circulatory Physiology. 2003, 284: H528-534.
 
50.
Evans MD, Pryor WA: Cigarette smoking, emphysema and damage to a1 proteinase inhibitor. American Journal of Physiology. 1994, 266: L593-L611.
 
51.
Gairola CG, Drawdy ML, Block AE, Daugherty A: Sidestream cigarette smoke accelerates atherogenesis in apolipoprotein E-/- mice. Atherosclerosis. 2001, 156: 49-55. 10.1016/S0021-9150(00)00621-3.
 
52.
Kool MJ, Hoeks AP, Struijker Boudier HA, Reneman RS, Van Bortel LM: Short- and long-term effects of smoking on arterial wall properties in habitual smokers. Journal of the American College of Cardiology. 1993, 22: 1881-1886.
 
53.
Lassila R, Seyberth H, Haapanen A, Scweer H, Koskenvuo M, Laustiola K: Vasoactive and atherogenic effects of cigarette smoking: a study of monozygotic twins discordant for smoking. British Medical Journal. 1988, 297: 955-957. 10.1136/bmj.297.6654.955.
 
54.
Mast H, Thompson JLP, Lin I-F, Hofmeister C, Hartmann A, Marx P, Mohr JP, Sacco RL: Cigarette smoking as a determinant of high-grade carotid artery stenosis in Hispanic, Black and White patients with stroke or transient ischemic attack. Stroke. 1998, 29: 908-912.
 
55.
Padro T, Emeis JJ, Steins M, Schmid KW, Kienast J: Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 1995, 15: 893-902.
 
56.
Blann AD, Kirkpatrick U, Devine C, Naser S, McCollum CN: The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis. 1998, 141: 133-139. 10.1016/S0021-9150(98)00163-4.
 
57.
Hioki Y, Aoki N, Kawano K, Homori M, Hasumura Y, Yasumura T, Maki A, Yoshino H, Yanagisawa A, Ishikawa K: Acute effects of cigarette smoking on platelet-dependant thrombin generation. European Heart Journal. 2001, 22: 56-61. 10.1053/euhj.1999.1938.
 
58.
Iso H, Shimamoto T, Sato S, Koike K, Ida M, Komachi Y: Passive smoking and plasma fibrinogen concentrations. American Journal of Epidemiology. 1996, 144: 1151-4.
 
59.
Khrenov AV, Ananyeva NM, Griffin JH, Saenko EL: Coagulation pathways in atherothrombosis. Trends in Cardiovascular Medicine. 2002, 12: 317-324. 10.1016/S1050-1738(02)00182-2.
 
60.
Nowak J, Andersson K, Benthin G, Chen J, Karlberg K-E, Sylven C: Effect of nicotine infusion in humans on platelet aggregation and urinary excretion of a major thromboxane metabolite. Acta Physiologica Scandinavica. 1996, 157: 101-107. 10.1046/j.1365-201X.1996.474216000.x.
 
61.
Simpson AJ, Gray RS, Moore NR, Booth NA: The effects of chronic smoking on the fibrinolytic potential of plasma and platelets. British Journal of Haematology. 1997, 97: 208-213. 10.1046/j.1365-2141.1997.d01-2137.x.
 
62.
Zhu BQ, Parmley WW: Hemodynamic and vascular effects of active and passive smoking. American Heart Journal. 1995, 130: 1270-1275. 10.1016/0002-8703(95)90154-X.
 
63.
Zidovetzki R, Chen P, Fisher M, Hofman F: Nicotine increases plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-associated pathway. Stroke. 1999, 30: 651-655.
 
64.
Zunker P, Schick A, Padro T, Kienast J, Phillips A, Ringelstein EB: Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: relation to stroke etiology. Neurological Research. 1999, 21: 727-732.
 
65.
Poredos P, Orehek M, Tratnik E: Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction. Angiology. 1999, 50: 201-8. 10.1177/000331979905000304.
 
66.
Celermajer D, Keld S, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield J: Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993, 88: 2149-2155.
 
67.
Terborg C, Bramer S, Weiller C, Rother J: Short-term effect of cigarette smoking in CO2-induced vasomotor reactivity in man: A study with near-infrared spectroscopy and transcranial Doppler sonography. Journal of the Neurological Sciences. 2002, 205: 15-20. 10.1016/S0022-510X(02)00308-8.
 
68.
Magyar M, Szikszai Z, Balla J, Valikovics A, Kappelmayer J, Imre S, Balla G, Jeney V, Csiba L, Bereczki D: Early onset carotid atherosclerosis is associated with increased intimamedia thickness and elevated serum levels of inflammatory markers. Stroke. 2003, 34: 56-63. 10.1161/01.STR.0000048845.83285.AC.
 
69.
Zhang B, Fugleholm K, Day LB, Ye S, Weller RO, Day IN: Molecular pathogenesis of subarachnoid haemorrhage. International Journal of Biochemistry and Cell Biology. 2003, 35: 1341-1360. 10.1016/S1357-2725(03)00043-8.
 
70.
Qureshi AI, Suarez JI, Parekh PD, Sung GY, Geocadin R, Bhardwaj A, Tamargo REJ, Ulatowski JA: Risk Factors for Multiple Intracranial Aneurysms. Neurosurgery. 1998, 43: 22-26. 10.1097/00006123-199807000-00013.
 
71.
Qureshi AI, Sung GY, Fareed SM, Straw RN, Guterman LR, Hopkins LN: Factors associated with aneurysm size in patients with subarachnoid haemorrhage: effect of smoking and aneurysm location. Neurosurgery. 2000, 46: 44-50. 10.1097/00006123-200001000-00009.
 
72.
Stone P, Gottlieb D, O'Connor G, Ciccolella D, Breuer R, Bryan-Rhadfi J, Shaw H, Franzblau C, Snider G: Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 1995, 151: 952-959.
 
73.
Tartara F, Gaetani P, Tancioni F, Guagliano A, Klersy C, Forlino A, Marzatico F, Rodriguez y, Baena R: Alpha1-antitrypsin activity in subarachnoid hemorrhage. Life Sciences. 1996, 59: 15-20. 10.1016/0024-3205(96)00263-9.
 
74.
Juvela S: Prevalence of risk factors in spontaneous intracerebral hemorrhage and aneurysmal sub-arachnoid hemorrhage. Archives of Neurology. 1996, 53: 734-740.
 
 
CITATIONS (10):
1.
Manufactured and hand-rolled cigarettes and smokeless tobacco consumption in Mozambique: Regional differences at early stages of the tobacco epidemic
Carla Araújo, Carla Silva-Matos, Albertino Damasceno, Maria Lídia Gouveia, Ana Azevedo, Nuno Lunet
Drug and Alcohol Dependence
 
2.
The Prognostic Effect of Cigarette Smoking on Stroke Severity, Disability, Length of Stay in Hospital, and Mortality in a Cohort with Cerebrovascular Disease
Rojiemiahd K. Edjoc, Robert D. Reid, Mukul Sharma, Jiming Fang
Journal of Stroke and Cerebrovascular Diseases
 
3.
Bi-directional associations between healthy lifestyles and mood disorders in young adults: The Childhood Determinants of Adult Health Study
S. L. Gall, K. Sanderson, K. J. Smith, G. Patton, T. Dwyer, A. Venn
Psychological Medicine
 
4.
A Clinical Imperative: Assisting Patients Who Smoke to Reduce Their Risk of Cardiovascular Disease
Chris Bullen, Robyn Whittaker, Hayden McRobbie, Karl Fagerström
Preventive Cardiology
 
5.
Predyktory rzucania palenia po udarze mózgu
Halina Sienkiewicz-Jarosz, Paweł Zatorski, Grzegorz Witkowski, Artur Rogowski, Anna Ścińska, Danuta Ryglewicz
Neurologia i Neurochirurgia Polska
 
6.
“Addressing the impact of stroke risk factors in a case control study in tertiary care hospitals”: a case control study in Tertiary Care Hospitals of Peshawar, Khyber Phukhtoonkhwa (KPK) Pakistan
Syed Muhammad Shah, Syed Muhammad Shah, Saima Khan, Shahzad Rehman, Zakir Khan, Wisal Ahmed, . Zubair
BMC Research Notes
 
7.
Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style
B. Fuentes, J. Gállego, A. Gil-Nuñez, A. Morales, F. Purroy, J. Roquer, T. Segura, J. Tejada, A. Lago, E. Díez-Tejedor, M. Alonso de Leciñana, J. Álvarez-Sabin, J. Arenillas, S. Calleja, I. Casado, M. Castellanos, J. Castillo, A. Dávalos, F. Díaz-Otero, J.A. Egido, J.C. López-Fernández, M. Freijo, A. García Pastor, F. Gilo, P. Irimia, J. Maestre, J. Masjuan, J. Martí-Fábregas, P. Martínez-Sánchez, E. Martínez-Vila, C. Molina, F. Nombela, M. Ribó, M. Rodríguez-Yañez, F. Rubio, J. Serena, P. Simal, J. Vivancos
Neurología (English Edition)
 
8.
Guía para el tratamiento preventivo del ictus isquémico y AIT (I). Actuación sobre los factores de riesgo y estilo de vida
B. Fuentes, J. Gállego, A. Gil-Nuñez, A. Morales, F. Purroy, J. Roquer, T. Segura, J. Tejada, A. Lago, E. Díez-Tejedor, M. Alonso de Leciñana, J. Álvarez-Sabin, J. Arenillas, S. Calleja, I. Casado, M. Castellanos, J. Castillo, A. Dávalos, F. Díaz-Otero, J.A. Egido, J.C. López-Fernández, M. Freijo, A. García Pastor, F. Gilo, P. Irimia, J. Maestre, J. Masjuan, J. Martí-Fábregas, P. Martínez-Sánchez, E. Martínez-Vila, C. Molina, F. Nombela, M. Ribó, M. Rodríguez-Yañez, F. Rubio, J. Serena, P. Simal, J. Vivancos
Neurología
 
9.
The Economic Impact of Smoking on the Treatment Costs of Stroke at a Tertiary Care Neurological Center in Mexico
Roger Humberto Quintana-Carrillo, Antonio Arauz, Daniel San-Juan, Iván Tomás López de Santiago, Lucinda Aguirre-Cruz, Teresa Corona, Luz Myriam Reynales-Shigematsu
International Journal of Stroke
 
10.
Ambient Intelligence
Alessandro Fenicio, Gaëlle Calvary
 
eISSN:1617-9625